Quick Summary
Covering the latest research from top Wall Street investment banks

HSBC Maintains a Buy Rating on WeRide, Target Price USD 11.40

Institution
HSBC
Date
2026-05-14
Authors
Yuqian Ding
Company
WERIDE INC
Ticker
WRD.US
Industry
Software - Application
Rating
Buy
BullishLow confidence1Q26 results were broadly in line with expectations, fleet expansion and commercialization momentum remained intact, and the target price is unchanged with about 49% upside implied versus the current share price.
AuthorsYuqian Ding
Target priceUSD 11.40
CoverageEurope
Asset classesEquity
Business segmentsrobotaxi、autonomous driving、WRD 3.0
Research firm divisions/subsidiariesHSBC(Other)

AI summary card

HSBC Maintains a Buy Rating on WeRide, Target Price USD 11.40

The report says 1Q26 revenue and gross profit were broadly in line with expectations, and quarterly volatility mainly reflected project delivery and recognition timing, customer validation schedules, holiday effects, and some deferred overseas deliveries rather than a deterioration in underlying demand trends.

Buy; target price USD11.40; current price USD7.65; expected upside +49.0%.
Earnings reviewMaintain BuyrobotaxiFleet rampDCF valuationOverseas commercialization
  • 1Q26 revenue was RMB114m, up 58% YoY; gross profit was RMB39.6m, up 56% YoY, with a gross margin of 35%.
  • As of end-April, about 1,300 robotaxis had been deployed, and the 2026 fleet guidance remains unchanged.
  • China robotaxi registered users were nearly double YoY, average daily orders per vehicle exceeded 17 in 1Q26, and peak daily orders reached 28.
  • DCF assumptions are unchanged, WACC is 11.6%, the target price remains USD11.40, and this implies about 49% upside versus the USD7.65 share price.

Report interpretation

Overview

This is HSBC's 1Q26 earnings review on WeRide (WRD.US). The report says the company's 1Q26 performance was broadly in line with expectations, with revenue growth but quarter-to-quarter volatility mainly driven by project-based revenue recognition, customer validation schedules, holiday effects, and some deferred overseas deliveries rather than a deterioration in underlying demand trends. HSBC maintains a Buy rating and a USD11.40 target price.

Core views

The core view is that fleet expansion and commercialization progress remain intact: as of end-April, about 1,300 robotaxis had been deployed, and the 2026 fleet guidance is unchanged; China operations continue to improve in user growth and utilization, while overseas expansion is progressing in markets such as Dubai, Singapore, and Slovakia. The report also believes the current share price is close to its bearish-scenario assumption, and with USD61m of the USD100m buyback plan already completed, the stock looks attractive.

Analysis framework

The report analyzes 1Q26 operating data, fleet deployment, robotaxi utilization, overseas project progress, and a DCF valuation framework. Forecasts and DCF assumptions are unchanged, and the ADR target price is derived using HSBC Global Investment Research's 2026 year-end USD/RMB forecast of 6.75.

Methodology notes

  • Valuation methodsDCF

    Discounted cash flow valuation

    HSBC values the company using the present value of free cash flow from 2026e-2035e and a 2.5% terminal growth rate. With a WACC of 11.6%, this implies enterprise value of RMB22.5bn and equity value of RMB26.5bn, which translates into a WRD.US target price of USD11.40.

  • ratingHSBC stock rating framework

    Upside relative to the current share price

    HSBC discloses that its Buy rating typically corresponds to more than 20% upside to the current share price; this report implies about 49% upside versus the current price.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • WRD.US
    Core coverage name
    Strengths
    Fleet ramp guidance remains unchanged, robotaxi utilization is improving, overseas commercialization continues to advance, and the buyback plan is still being executed.
    Weaknesses
    The company remains in a loss-making and cash-consuming phase, and revenue recognition is heavily influenced by project delivery timing.
    Comparison
    The report believes the current valuation is close to its bearish-scenario assumption, while the target price still implies about 49% upside versus the current share price.
    Risks
    Regulatory approval delays, competition from scaled L3 players, overseas execution uncertainty, and potential equity financing dilution.
  • 800 HK
    Corresponding H-share listing
    Strengths
    HSBC also maintains a HKD29.60 target price.
    Weaknesses
    Affected by ADR/H-share conversion, exchange rates, and liquidity.
    Comparison
    Derived using USD/HKD 7.80 and an ADR:H-share conversion ratio of 3.
    Risks
    Shares the same commercialization, regulatory, and financing risks as WRD.US.
  • Joyson Electronics A (600699.SS)
    Related beneficiary stock
    Strengths
    As a key safety hardware supplier to robotaxi players, it could benefit from broader robotaxi adoption.
    Weaknesses
    It is not a core coverage name in this report, so information is limited.
    Comparison
    HSBC mentions its Buy rating and RMB38.90 target price.
    Risks
    Affected by the pace of robotaxi industry adoption and supply chain competition.

Key data

  • 1Q26 revenueRMB114mUp 58% YoY.
  • 1Q26 gross profitRMB39.6mUp 56% YoY, with a 35% gross margin.
  • Target priceUSD11.40Unchanged from the prior target price.
  • Current share priceUSD7.65Market data as of the May 13, 2026 close.
  • Expected upside+49.0%Based on the USD11.40 target price and the USD7.65 share price.
  • Robotaxis deployedabout 1,300As of end-April.
  • 1Q26 average daily orders per vehiclemore than 17Peak daily orders reached 28.
  • DCF WACC11.6%Cost of equity 13.8%, cost of debt 3.0%.
  • 2026e revenue forecastRMB962mThe chart shows revenue continuing to grow from 2025a to 2028e.
  • 2028e revenue forecastRMB3,554mHSBC expects revenue to increase significantly versus 2026e.

Impact & implications

If fleet deployment, city-level commercialization, and overseas project execution proceed as expected, WeRide's revenue recognition could improve during the rest of 2026, and valuation may benefit from greater visibility into robotaxi commercialization. But the company is still in an investment phase, net profit and free cash flow are expected to remain negative in 2026e-2028e, and the share price is sensitive to regulatory progress, the competitive landscape, and financing expectations.

Risks

  • Regulatory approvals or commercialization permits could move slower than expected, especially for cross-district and city-level operations in Tier-1 cities.
  • Safety incidents could temporarily tighten the regulatory pace, increasing share price volatility.
  • The entry of scaled L3 players, OEMs, and Tier-1 suppliers could compress the window for independent robotaxi operators to build density and operating moats.
  • If the company overinvests in overseas expansion while domestic fleet scale lags, its competitive position in China could weaken.
  • Overseas markets such as the Middle East involve policy, geopolitical, and local execution uncertainties.
  • The international model built around partnerships with third-party platforms such as Uber creates cross-border execution, profitability, and scalability risks.
  • Continued cash burn and the early-stage nature of the business may create equity financing needs, which could dilute shareholders and pressure sentiment.

What to watch

  • Whether 2026 fleet deployment continues to meet guidance.
  • Disclosure on commercialization progress in the 2Q26 update.
  • Licensing, operations, and order progress in overseas projects such as Dubai, Singapore, and Slovakia.
  • Changes in China robotaxi registered users, average daily orders per vehicle, and peak utilization.
  • Whether regulators support cross-district and city-level commercial operations in Tier-1 cities.
  • The execution pace of the remaining portion of the USD100m buyback plan.
  • Free cash flow, cash balance, and any signs of potential equity financing.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins